Eric G. Carter

Business address
C/O King Pharmaceuticals, Inc., 501 Fifth Street, Bristol, TN, 37620
Top holdings (ownership)
AEON
Get insider transactions for this reporting owner
Eric G. Carter has filed 36 SEC EDGAR filings since 26 Jan 2007

Latest Filings

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open Document Open Filing 23 May 2025 21 May 2025 001-40021
4 Open Document Open Filing OWNERSHIP DOCUMENT 04 Sep 2024 31 Aug 2024 001-40021
4 Open Document Open Filing OWNERSHIP DOCUMENT 21 Mar 2024 19 Mar 2024 001-40021
4 Open Document Open Filing OWNERSHIP DOCUMENT 16 Aug 2023 14 Aug 2023 001-40021
4 Open Document Open Filing OWNERSHIP DOCUMENT 24 Jul 2023 21 Jul 2023 001-40021
3 Open Document Open Filing OWNERSHIP DOCUMENT 24 Jul 2023 21 Jul 2023 001-40021
4 Open Document Open Filing FORM 4 SUBMISSION 25 Jun 2020 23 Jun 2020 001-36579
4 Open Document Open Filing FORM 4 SUBMISSION 02 Aug 2019 31 Jul 2019 001-36579
4 Open Document Open Filing FORM 4 SUBMISSION 15 Jun 2018 31 May 2018 001-36579
4 Open Document Open Filing FORM 4 SUBMISSION 25 Apr 2018 23 Apr 2018 001-36431
3 Open Document Open Filing FORM 3 SUBMISSION 25 Apr 2018 23 Apr 2018 001-36431
4 Open Document Open Filing FORM 4 SUBMISSION 08 Sep 2017 07 Sep 2017 001-36579
3 Open Document Open Filing FORM 3 SUBMISSION 08 Sep 2017 07 Sep 2017 001-36579